Article Text

Download PDFPDF
Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England
  1. Adrian R Kendal1,
  2. Daniel Prieto-Alhambra1,2,3,4,
  3. Nigel K Arden1,2,
  4. Andrew Carr1,
  5. Andrew Judge1,2
  1. 1National Institute for Health Research Oxford Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Headington, Oxford OX3 7LD, UK
  2. 2MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK
  3. 3URFOA-IMIM (Unitat de Recerca en Fisiopatologia Ossia i Articular) and RETICEF (Red Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad), Parc de Salut Mar, Barcelona, Spain
  4. 4GREMPAL (Grup de Recerca en Malalties Prevalents de l'Aparell Locomotor) Research Group, IDIAP (Institut d'Investigacio en Atencio Primaria) Jordi Gol Primary Care Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
  1. Correspondence to: A Carr; andrew.carr{at}


STUDY QUESTION How do 10 year mortality rates compare between patients undergoing metal-on-metal (MoM) hip resurfacing and those undergoing total hip replacement in England?

SUMMARY ANSWER Patients in England with hip osteoarthritis who underwent MoM hip resurfacing between 1999 and 2012 have reduced long term mortality compared with those who underwent cemented and uncemented THR.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.